Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126101781 | 12610178 | 1 | I | 20160415 | 0 | 20160729 | 20160729 | DIR | 67.00 | YR | M | N | 207.00000 | LBS | 20160728 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126101781 | 12610178 | 1 | PS | LUPRON | LEUPROLIDE ACETATE | 1 | Intramuscular | 0 | |||||||||||
| 126101781 | 12610178 | 3 | C | ALENDRONATE | ALENDRONATE SODIUM | 1 | 0 | ||||||||||||
| 126101781 | 12610178 | 5 | C | CALCIUM | CALCIUM | 1 | 0 | ||||||||||||
| 126101781 | 12610178 | 7 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126101781 | 12610178 | 1 | Prostate cancer |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126101781 | 12610178 | Arthralgia | |
| 126101781 | 12610178 | Dyspnoea | |
| 126101781 | 12610178 | Hot flush | |
| 126101781 | 12610178 | Libido decreased | |
| 126101781 | 12610178 | Muscular weakness | |
| 126101781 | 12610178 | Sleep disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126101781 | 12610178 | 1 | 20160126 | 0 |